Mission Impossible? Development of an EMR-Driven Screening Pathway for HCV Patients in Alberta.
CWSF · 2026 Disease & Illness
Overview
Hepatitis C Virus (HCV) is a high mortality disease identified as one of the Top 10 eradicable global diseases. In Alberta, there are about 19,000 HCV patients, with 50 -75% being undiagnosed and untreated. This is due to the lack of a standardized screening pathway in the community. This project built and implemented a predictive AI clinical screening tool, linking lost patients back to specialist care. It engaged 385,000 patients in 87 clinics with 381 family physicians in Calgary and uncovered 50 previously unidentified HCV patients. These are 50 patients linked to a cure due to this study. Results showed these 50 patients had similar predictive risk factors such as race (white), male, clear history of IV drug use, alcohol abuse and/or incarceration. Currently, this study is expanding to test these population-based risk factors in rural Alberta, and to target vulnerable cohorts such as the Indigenous population.
Awards (1)
- Selected for CWSF 2026
Competition history
- CWSF 2026
Related projects
ISEF · 2015
Development of a Novel Biomarker Algorithm for the Early Detection of Liver Cancer
CWSF · 2026
Precision Allocation of GLP1-RA and SGLT2i in Cardiac Rehabilitation
ISEF · 2024
Novel Utilization of Blood Work Monitoring (NavDx) for Early Detection of Cervical and Anal Cancers
ISEF · 2024
A Holistic Multi-Modal GenAI System: Early Detection and Predictive Treatment Monitoring Using Chest X-rays and Cough Audio for Tuberculosis
Closest projects by meaning, across every fair and year in the corpus.